Menu Menu

News

How should we share living guidelines with and for people with lived experience?

11 June, 2024
In this video, Dr Anneliese Synnot talks about the results of an ALEC survey of community members / people with lived experience about how we should share living guidelines with them. Below, we provide a more detailed summary of the study and its results. What are living guidelines? Living guidelines are evidence-based statements that make recommendations to help health professionals...
Video

Updated research evidence at our fingertips – what are the implications and considerations for health policy? Stay in touch!

22 April, 2024
Updated research evidence at our fingertips - what are the implications and considerations for health policy? Stay in touch! Living evidence is gaining interest from policymakers, and researchers...
News

Get set: LEAPP Process evaluation launching this month

9 April, 2024
The ALEC team is all set to launch a process evaluation of the LEAPP guidelines later this month. The ongoing evaluation will help us identify opportunities for improvement...
News

Designing, refining and reflecting on 3 years of daily evidence surveillance for Australia’s living COVID-19 guidelines

21 March, 2024
A new paper out this week by Cochrane Australia co-director and information specialist Steve McDonald charts how a talented team provided daily global evidence surveillance and rapid updates...
News

More than words: sharing research and resources on grief and PTSD for parents and healthcare professionals

28 February, 2024
The ALEC Team recently discovered we had a prize winning videographer in our midst and wanted to find out more. It was revealed that before joining us, Research...
Video

Guiding ALEC’s future steps: A look at the incredible people involved with our Strategic Advisory Committee

28 February, 2024
ALEC’s new Strategic Advisory Committee marks an exciting chapter for the collaboration. We’re incredibly grateful to have such a stellar group of experts involved to help steer our...
News

RECOVERY trial group publishes study results for children with COVID-19 associated PIMS (PIMS-TS)

22 February, 2024
While funding for our COVID Taskforce ended last year, we still like to keep an eye on the evidence. Here, ALEC’s Director of Evidence and Methods Heath White...
News

2024: the LEAPP year of the consumer

22 February, 2024
According to the Lunar calendar, 2024 is the year of the dragon. Here at ALEC, it’s also shaping up to be the year of the consumer. For the...
News

ALEC Pre-Budget Submission 2024-25: five key recommendations to build on Australian success as a global leader in living evidence & clinical guidelines

15 February, 2024
As this year’s Australian Living Evidence Collaboration (ALEC) Pre-Budget Submission highlights, the Commonwealth Government has supported Australia to become a global leader in the development and application of...
News

Celebrating the extraordinary Sharon McGowan AM

15 February, 2024
The Chair of ALEC’s Strategic Advisory Committee, and CEO of the Royal Australian and New Zealand College of Psychiatrists, Sharon McGowan was appointed as a Member of the...
News

Share your feedback on the first new Australian Postnatal Care Guidelines recommendation on alcohol and breastfeeding

14 February, 2024
The first recommendation of the new Australian Postnatal Care Guidelines was published this week and is now open for comment. Here, Living Evidence for Pregnancy and Postnatal Care...
News

New Cochrane review weighs up the evidence on public health communication & Covid-19: what worked, what didn’t & why

17 January, 2024
While funding for our COVID Taskforce ended last year, we still like to keep an eye on the latest research. ALEC Communications Director Shauna Hurley was also keen...
News

National roundtable on miscarriage aims to raise awareness and improve support

17 October, 2023
Miscarriage is a devastating and traumatic experience that affects an estimated 110,000 women and families each year in Australia. These figures and the grief that lies behind them...
News

What’s in a name? ALEC puts collaboration front and centre

19 September, 2023
Earlier this month the Australian Living Evidence Consortium made a slight but purposeful change to our name. Here, we explain why we’ve just become the Australian Living Evidence...
News

LEAPP: And so it begins…

2 August, 2023
This week marked an exciting milestone for the LEAPP Team, with our first Pregnancy Panel and Postnatal Panel meetings kicking off a five year program of evidence review...
News

NCET funding discontinued

5 July, 2023
Funding has now been discontinued for the National Clinical Evidence Taskforce and the COVID-19 guidelines as of 30 June 2023. These guidelines are no longer continually updated but...
News

NCET funding update: June 2023

6 June, 2023
The National Clinical Evidence Taskforce (NCET) continues to face funding uncertainty post  June 30, but has renewed calls for federal funding. NCET submitted a proposal to government last...
News

Taskforce commits to addressing Equity, Diversity and Inclusion issues within COVID-19 guideline

30 May, 2023
Earlier this year, the National Clinical Evidence Taskforce (NCET) committed to better addressing issues of equity, diversity and inclusion (EDI) within the COVID-19 guidelines, starting by reporting on...
News

Equity Trustees fund vital living evidence and a visual journey

22 May, 2023
In July 2022, the World Health Organization declared MPX (also known as monkey pox and mpox) a global public health emergency , and Australia’s Chief Medical Officer declared...
News

MPX Living Guidelines retirement reflects shifting national and international health landscapes

22 May, 2023
Late last year, the National Clinical Evidence Taskforce (NCET) scaled up to gather the latest evidence on the emerging public health threat of MPX – or Monkey Pox...
News

Taskforce welcomes the Inquiry recommendations for long COVID living guidelines

5 May, 2023
The National Clinical Evidence Taskforce welcomes recommendations from the Parliamentary Inquiry into Long COVID and Repeat COVID Infections to “[develop] evidence-based living guidelines for diagnosis and treatment incorporating...
Media Release

Taskforce turns three

27 April, 2023
By Kayla Voss A global health crisis demanded unity to aid an Australian healthcare system primed to bear the weight of its consequences. Three years on, the National...
News

Congratulations to Consumer Panel Member, Joanne Muller

2 February, 2023
The Taskforce congratulates Consumer Panel member, Joanne Muller, on her appointment to the Australia Day Honours List. We're delighted she was recognised for her significant service to youth,...
News

Message from the Chair & Executive Director

20 December, 2022
Dear colleagues, This year has been filled with both achievements and challenges. While there have been many changes, the impact of the pandemic continues to be substantial, especially...
News

National Clinical Evidence Taskforce Funding Update

15 December, 2022
Earlier this week the National Clinical Evidence Taskforce was informed that the Commonwealth Department of Health and Aged Care will not be continuing our contract to develop clinical...
News

Taskforce updates molnupiravir guidance following PANORAMIC trial results

2 December, 2022
The Taskforce has incorporated the preliminary results of the PANORAMIC trial into the body of evidence for oral antiviral molnupiravir (Lagevrio). This large (25,783 participants) open-label randomised controlled...
News

CPR flowcharts updated

29 November, 2022
Flowcharts regarding COVID-19 management have been updated for CPR preparedness and CPR delivery in clinical and care settings, and for basic life support in the community. These updates incorporate the most recent...
News

New TaskforceTV episode – Understanding MPX

22 November, 2022
In our first episode on MPX, host Tari Turner speaks with Dr Nicholas Medland on what we know about the disease and the importance of clinicians recognising the...
Video

Taskforce submission to long COVID inquiry

18 November, 2022
The Taskforce today submitted its response to the Commonwealth Parliamentary inquiry into Long COVID and repeated COVID infection. Led by the Taskforce Primary and Chronic Care Panel, with contributions...
News

New look and new scope for the Taskforce

27 October, 2022
Dear colleagues It’s hard to comprehend we are approaching the end of our third year of living with COVID-19. What an extraordinary time to be in healthcare as...
News

Taskforce updates post-COVID-19 flowchart

8 September, 2022
The National COVID-19 Clinical Evidence Taskforce has published an updated flowchart for care of people after COVID-19. The new version applies to adults, adolescents and children with signs...
News

Meet the Evidence Team: Samantha Chakraborty

19 August, 2022
Read our Q&A with Sam Chakraborty, Primary & Chronic Care Panel Methods Chair:   Please tell us about yourself and your role with the Taskforce  I’m Samantha Chakraborty....
News

Meet the Evidence Team: Annie Synnot

5 August, 2022
Read our Q&A with Annie Synnot, Consumer Panel Methods Chair: Introduce yourself and your role with the Taskforce/Consumer Panel. Hi, I’m Annie Synnot and I’m based in Adelaide....
News

Vaccine language changes in paediatric and pregnancy recommendations

2 August, 2022
Further to recent changes to vaccine status across the recommendations for adults with mild COVID-19, the following paediatric and pregnancy recommendations have now been updated: Nirmatrelvir plus ritonavir...
News

Update to recommendations for adults with mild COVID-19

21 July, 2022
To reflect changing language from ATAGI and to remove confusion among clinicians about what ‘up-to-date’ with vaccination means, the Taskforce has replaced this terminology across all relevant adult...
News

Meet the Evidence Team: Alex Poole

15 July, 2022
Read our Q&A with Alex Poole: Can you introduce yourself and your role at the Taskforce? I’m Alex Poole. I’m a trained Critical Care Nurse and clinical researcher...
News

I have mild COVID – should I take the antiviral Paxlovid?

30 May, 2022
How effective is Paxlovid in treating mild COVID-19? Taskforce Director, Tari Turner, together with Primary Chronic Care Co-Chairs Nicole Allard and Mark Morgan and Disease-Modifying Treatments & Chemoprophylaxis...
News

SMS Notification System

10 May, 2022
To provide a more immediate and tailored notification system, current and new subscribers can now also opt-in to receive an SMS notification regarding any new recommendation or update to the Australian...
News

Taskforce updates Sotrovimab remark (v54.0)

28 March, 2022
The Taskforce has updated the remarks on its sotrovimab 'for use' recommendations to include: The Taskforce is aware of in vitro data suggesting a potential reduction in efficacy...
News

Consumer Panel Recruitment

10 March, 2022
Would you like to use your experience to improve the care of Australians with COVID-19? The National COVID-19 Clinical Evidence Taskforce is seeking two new members to join...
News

I’ve tested positive for COVID-19? What treatments are available?

9 March, 2022
  With several new drug treatments for people with mild COVID-19 now available, it can be tricky to know what your options are should you test positive to...
Uncategorised

Taskforce notes TGA provisional approval for Evusheld

25 February, 2022
The Taskforce notes that on Friday, February 24, 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for tixagevimab and cilgavimab (Evusheld) for pre-exposure prophylaxis (prevention). Taskforce guidance...
News

Welcome ACNN – new member organisation

15 February, 2022
We are excited to welcome the Australian College of Neonatal Nurses (ACNN), who have joined the Taskforce as a new member organisation. As COVID-19 cases continue to spread...
News

Welcome RMSANZ – new member organisation

31 January, 2022
The Taskforce is delighted to welcome the Rehabilitation Medicine Society of Australian and New Zealand (RMSANZ) as a new member of the Taskforce. With many Australians now recovering...
News

Taskforce notes concerns about potential Ronapreve effectiveness and Omicron

23 December, 2021
The Taskforce has added the following statement to the remark in all for use casirivimab plus imdevimab recommendations. The Taskforce is aware of concerns about the potential for...
News

Taskforce summer holiday schedule

17 December, 2021
The Taskforce project team will take a well-earned break from December 22, 2021 through to January 17, 2022. The Taskforce will continue to monitor the latest global research findings...
News

Paediatric and Adolescent Care Panel publish paper in MJA

29 October, 2021
Led by Panel Co-Chairs A/Prof Asha Bowen and Dr Brendan McMullen, together with Methods Chair Dr David Fraile Navarro the Taskforce this week published a paper in the Medical Journal of...
News

Guidelines update, v44.1

21 October, 2021
Version 44.1 of the Australian guidelines for the clinical care of people with COVID-19 includes an addition to the remark for prone positioning for adults: For adults with...
News

Taskforce Executive Director passes the leadership baton

15 October, 2021
Founding Executive Director of the Taskforce, Professor Julian Elliott, this week stepped down as leader after 18 months at the helm. Julian was instrumental in the establishment of the Taskforce in...
News

Taskforce makes conditional recommendation for use of sotrovimab 

26 August, 2021
The National COVID-19 Clinical Evidence Taskforce today published three recommendations on the use of sotrovimab for the treatment of COVID-19 in adults who do not require oxygen and...
Media Release

Coverage: Understanding evidence

17 August, 2021
Science reporter for the The Age and Sydney Morning Herald, Liam Mannix explains the critical role of gold standard evidence and highlights the role of Cochrane and the...
News

Taskforce amends remarks for Tocilizumab in response to critical shortage

5 August, 2021
This week the Taskforce was alerted by the Therapeutic Goods Administration (TGA) to a global tocilizumab shortage for both COVID-19 treatment use and other indications. To help support...
News

Guidelines update, v41.2

22 July, 2021
Version 41.2 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of two new studies on disease-modifying treatments: Canakinumab NEW – one...
News

EXPLAINER: What happens if I test positive to COVID-19?

19 July, 2021
With the recent COVID-19 outbreak in NSW and Victoria, it’s timely to revisit what happens if you test positive with COVID-19.  With so much media commentary and coverage...
Uncategorised

Guidelines update, v41.1

15 July, 2021
Version 41.1 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of six new studies on disease-modifying treatments. Convalescent plasma - two...
News

Guidelines update, v40.3

25 June, 2021
Version 40.3 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of several new studies on disease-modifying treatments as well as an...
News

Guidelines update, v40.2

17 June, 2021
Version 40.2 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of three new studies on disease-modifying treatments. In addition, the treatment...
News

Taskforce publishes guidance to help healthcare workers and organisations make decisions about PPE during the COVID-19 pandemic

10 June, 2021
Following today’s publication of the Infection Control Expert Group (ICEG)’s Guidance on the use of personal protective equipment (PPE) for health care workers in the context of COVID-19,...
News

Head to ATAGI or NCIRS for vaccine advice

28 May, 2021
The Taskforce is responsible for treatment guidelines for the management of COVID-19. The body responsible for vaccine advice is the Australian Technical Advisory Group on Immunisation (ATAGI). For...
News

Guidelines update, v39.1

28 May, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week includes the following change to the evidence summary section for:   REGN-COV2 The...
News

Guidelines update, v38.3

13 May, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   Convalescent plasma...
News

Steve McGloughlin: A team approach in an intensive year

7 May, 2021
When the COVID-19 pandemic took hold in early 2020, the Intensive Care Unit (ICU) team at The Alfred hospital in Melbourne set itself the goal that no one...
News

WEBINAR – Murray PHN hosts ‘Long COVID Symptoms: Management of long term effects’

6 May, 2021
International event hosted by Dr Norman Swan LONG COVID SYMPTOMS: Management of long term effects – what is known so far? Taskforce Senior Evidence Officer and Primary Care...
News

? WEBINAR: Living Evidence, COVID-19 and consumers?

4 May, 2021
Learn how the Taskforce develops living guideline recommendations and the role of consumers If you missed the recent webinar hosted by Consumers Health Forum of Australia, you can...
Video

Guidelines update, v38.1

29 April, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   - Lopinavir-ritonavir...
News

Webinar: Living Evidence and consumers

22 April, 2021
Are you interested in developing a better understanding of how clinical guidelines can be kept up-to-date with the latest evidence as new research emerges? The Taskforce is proud...
News

Guidelines update, v37.1

15 April, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include the following changes to the evidence summary sections for:   - Corticosteroids...
News

Guidelines update, v36.1

25 March, 2021
Update to the Australian guidelines for the clinical care of people with COVID-19 this week includes:   Bromhexine hydrochloride - additional study has been added to the summary...
News

Taskforce continuing to recruit HCWs for IPC consultation

18 March, 2021
The Taskforce will soon be conducting a series of consultations with frontline healthcare workers to provide feedback on the implementability of draft infection prevention and control (IPC) recommendations....
News

Taskforce statement on vaccination

15 March, 2021
The Taskforce and its 33-member organisations unanimously support vaccination as the best protection against serious illness or death from COVID-19. Please refer to the Australian Technical Advisory Group...
News

Guidelines update, v35.2

11 March, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include:   Tocilizumab - The reference for one included study (Wang et al.) was...
News

Women who lead: Sutapa Mukherjee and her journey to the Taskforce

8 March, 2021
As the female co-chair of the Taskforce Guidelines Leadership Group, the contribution of Associate Professor Sutapa Mukherjee in the fight against COVID-19 is reason enough to be recognised...
News

Guidelines update, v35.1

4 March, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include: Tocilizumab - The references for REMAP-CAP and COVACTA (Rosas et al.) trials have...
News

WANTED: Frontline healthcare workers for IPC recommendations consultation

3 March, 2021
The Taskforce is currently recruiting frontline healthcare workers in Australia to volunteer to participate in a series of consultations to provide feedback on the implementability of draft IPC...
News

Seeking consumers and carers with lived experience of COVID-19

24 February, 2021
Share your lived experiences of COVID-19 and contribute to the national guidelines The Taskforce welcomes people who have been affected by COVID-19 to join the Consumer Panel.  The...
News

Guidelines update, version 34.1

18 February, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include:   Dutasteride - preprint publication status has been removed from the summary information...
News

RECOVERY Trial publishes tocilizumab results

12 February, 2021
The Taskforce notes the publication of results of the tocilizumab arm of the RECOVERY trial in medRxiv Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results...
News

Guidelines update, version 33.1

5 February, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include: Additional study (Mohan et al.) added to the summary information for Ivermectin recommendation: We...
News

Statement on joint media release from the REMAP-CAP, ACTIV-4 and ATTACC trials regarding anticoagulation

24 December, 2020
The Taskforce acknowledges the publication of a joint media release from the REMAP-CAP, ACTIV-4 and ATTACC trial teams on December 22nd, 2020. The investigators have reported that among...
News

Taskforce recommendations for remdesivir unchanged following detailed analysis of disease severity subgroups

18 December, 2020
The Taskforce has completed a comprehensive review to assess the credibility of disease severity subgroups used in its recommendations on remdesivir. This was initiated following the World Health Organisation...
News

2020 in review

18 December, 2020
This week marks our 36th weekly guidelines update which now incorporates 118 living guideline recommendations, 10 living clinical flowcharts, and covers over 100 clinical questions. The Taskforce website has been viewed...
News

Greater than the sum of its parts: how The Ian Potter Foundation’s early and generous support helped the Taskforce deliver in 2020

9 December, 2020
Looking back over what’s universally recognised as a most extraordinary year, the National COVID-19 Clinical Evidence Taskforce represents something greater than the sum of its parts. On one...
News

New expert panel to bring latest evidence and clinical experience together to prevent COVID-19 transmission in healthcare settings

30 November, 2020
The National COVID-19 Clinical Evidence Taskforce has today announced the membership of its new expert panel for infection prevention and control (IPC), which will be jointly chaired by...
News

A year like no other: Professor Carol Hodgson takes a look back at the collaboration, collegiality and contributions inspired by COVID-19

28 November, 2020
Professor Carol Hodgson knows first-hand the challenges facing frontline health workers, researchers and guideline developers in the time of COVID. A few months into 2020, she was already...
News

Help shape the guidelines

19 November, 2020
The second Taskforce impact survey was launched today. We are calling on Australian healthcare practitioners to participate in a brief 5-minute survey to help us understand how the...
News

Care and comfort in the time of COVID: Natasha Smallwood takes a holistic approach to health

11 November, 2020
‘COVID is one of those illnesses that speaks to how much we need a holistic approach to care and comfort,’ says Associate Professor Natasha Smallwood, Deputy Chair of...
News

Julian Elliott on ANZICS ‘Meet the Experts’ podcast

10 November, 2020
This week Taskforce Executive Director, A/Prof Julian Elliott, was interviewed by Dr Swapnil Pawar on ANZICS Meet the Experts podcast to discuss the processes and challenges involved in forming the...
News

ANZJOG publishes Taskforce paper

2 November, 2020
Led by A/Prof Joshua Vogel, the Australian and New Zealand Journal of Obstetrics and Gynaecology (ANZJOG) has published an early access version of a Taskforce paper on the Clinical...
News

IPC Panel Co-Chairs announced

29 October, 2020
The Taskforce and the Infection Control Expert Group (ICEG) today announced the appointments of Dr Phillipa Hore and A/Prof John Ferguson as Co-Chairs for the new Infection Prevention...
News

Saving lives safely: Adj Clin Prof Simon Craig on adult CPR in healthcare settings during COVID-19.

22 October, 2020
The COVID-19 pandemic has raised significant concerns about healthcare provider safety. In particular, clinicians have had to grapple with what is safe, or not safe to do in...
Video

Saving lives safely: Prof Peter Morley on Basic Life Support in the community during COVID-19.

22 October, 2020
Emerging data suggests that survival rates for out-of-hospital cardiac arrest have fallen during the COVID-19 pandemic, and this may be because first responders are delaying commence of CPR...
Video

Saving lives safely during COVID-19: CPR flowcharts explained

22 October, 2020
Why were the flowcharts developed? The Taskforce received feedback from hospital and community representatives citing a hesitation to commence resuscitation of people in cardiac arrest during the COVID-19...
Uncategorised

Saving lives safely: Taskforce issues guidance on CPR during the pandemic

22 October, 2020
Healthcare workers and trained first aid responders are being urged not to delay commencing cardiopulmonary resuscitation (CPR) because of the COVID-19 pandemic. The National COVID-19 Clinical Evidence Taskforce,...
Media Release

COVERAGE: A/Prof Julian Elliott on Trump treatment

7 October, 2020
Our Executive Director, A/Prof Julian Elliott spoke with Liam Mannix from The Age and Sydney Morning Herald about President Trump's treatment for COVID-19.      
News

COVERAGE: COVID ‘long-haulers’, A/Prof Elliott on Saturday AM

26 September, 2020
Our Executive Director, A/Prof Julian Elliott joined Linda Mottram on ABC Radio's Saturday AM program to discuss the importance of recognising prolonged symptoms after the acute phase of...
News

Navigating COVID-19 ‘tiger country’

22 September, 2020
In the first of a new series profiling Taskforce members, we catch up with Professor Josh Davis. An Infectious Diseases physician at Newcastle’s John Hunter Hospital and researcher...
News

What happens if I get COVID-19?

15 September, 2020
Finding trusted answers amid the widespread coverage of questionable claims and dubious data on unproven treatments is not easy. The good news is there are clear guidelines and...
News

New palliative care flowchart

10 September, 2020
The Care of Older People and Palliative Care Panel has published a clinical flowchart for the Management of people with COVID-19 who are receiving palliative care. Co-Chair of the...
News

Commonwealth announces new ICEG/Taskforce partnership

9 September, 2020
Commonwealth Minister for Health, the Hon Greg Hunt MP, this week announced the establishment of a new partnership between the Infection Control Expert Group (ICEG) and the Taskforce as...
News

New evidence of life-saving benefit of corticosteroids in critically ill people with COVID-19

3 September, 2020
A landmark meta-analysis conducted for the World Health Organisation was published in JAMA this week, reporting that corticosteroid use improves survival in critically ill patients with COVID-19. The analysis pooled...
News

Landmark publication of COVID-19 Core Outcomes Set

26 August, 2020
Our congratulations to Taskforce colleagues Professor Allison Tong and the COVID-19-Core Outcomes Set (COS) Workshop Investigators on publication of their landmark work in Critical Care Medicine. The paper reports...
News

Taskforce contribution commended by Victorian Government

25 August, 2020
Victorian Premier Daniel Andrews this week highlighted the state's support for the work of world-leading medical researchers, making significant strides in the battle against Coronavirus. Taskforce Executive Director, A/Prof Julian Elliott...
Video

Coverage: Taskforce hydroxychloroquine recommendation

5 August, 2020
Science reporter for the The Age and Sydney Morning Herald, Liam Mannix spoke to Taskforce Executive Director, A/Prof Julian Elliott regarding the 'Do Not Use' recommendation for the...
News

Pregnancy and perinatal care guideline recommendations

23 July, 2020
This week Professor Caroline Homer AO, Co-Chair of the Pregnancy and Perinatal Care Panel, explains the recent guideline recommendations which cover: Mode of birth Breastfeeding Rooming-in
Video

Taskforce makes recommendation for use of dexamethasone for patients receiving oxygen

3 July, 2020
The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of dexamethasone for the treatment of people with COVID-19 who are receiving oxygen or mechanical ventilation. The...
Media Release

Statement from the National COVID-19 Clinical Evidence Taskforce on media release of results of dexamethasone arm of the UK RECOVERY Trial

17 June, 2020
The National COVID-19 Clinical Evidence Taskforce (the Taskforce) has noted the media release of preliminary results from the dexamethasone arm of the RECOVERY (Randomised Evaluation of COVid-19 thERapY)...
Media Release

Taskforce issues first recommendation for drug treatment for COVID-19

5 June, 2020
The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of remdesivir in treatment of people with COVID-19. The Taskforce is comprised of 28 peak health...
Media Release